Ventricular assist devices
End Stage Heart Failure in Hospice
ECMO: What Could Go Wrong? by Murphy
ISHLT/MCSD Analysis: Jan 2002 – Dec 2004, n=655 178 Deaths * censored at transplant Percent Survival Months after Device Implant Deaths / Month Event:
J Heart Lung Transplant 2004; 23: 1027-1034 Continuous Patient Characteristics at Hospital Admission MeasurementMeanMinimumMaximumStd. Error Age at admission50.2710790.68.
Cost-Effectiveness of Left Ventricular Assist Devices (LVADs) as Permanent Implants for End-Stage Heart Failure David Samson Blue Cross and Blue Shield.
HeartMate II Left Ventricular Assist Device (LVAD) Courtesy University of Washington Medical Center.
Stanford Hospital & Clinics Pre-VAD Education VAD team Lisa Guertin, NP VAD Coordinator.
Palliative care in heart failure: reflections on the management of care Professor Philip J Larkin Joint Chair in Clinical Nursing ( Palliative Care) University.
21st Century Treatment of Heart Failure: Synchronizing Surgical & Medical Therapies for Better Outcomes
Prevencion Fallo Derecho
TREATMENT OF HEART FAILURE From Oral Medications to Intravenous Drips Mark Puhlman MSN ANP.
